Eberhardt Grube
#152,936
Most Influential Person Now
Eberhardt Grube's AcademicInfluence.com Rankings
Eberhardt Grubeengineering Degrees
Engineering
#6249
World Rank
#7565
Historical Rank
Biomedical Engineering
#539
World Rank
#549
Historical Rank

Eberhardt Grubephilosophy Degrees
Philosophy
#8528
World Rank
#11933
Historical Rank
Logic
#5560
World Rank
#6967
Historical Rank

Download Badge
Engineering Philosophy
Eberhardt Grube's Degrees
- PhD Biomedical Engineering University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is Eberhardt Grube Influential?
(Suggest an Edit or Addition)Eberhardt Grube's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. (2005) (2484)
- Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients (2017) (1992)
- Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. (2007) (1694)
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions (2003) (1093)
- TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions (2003) (975)
- Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. (2007) (960)
- Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. (2010) (782)
- Safety of Transesophageal Echocardiography: A Multicenter Survey of 10,419 Examinations (1991) (745)
- Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study (2006) (703)
- Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. (2008) (688)
- Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. (2011) (659)
- Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. (2005) (558)
- Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations: The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study (2009) (506)
- Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment (2007) (463)
- Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II (2005) (411)
- Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. (2012) (368)
- TAXUS III Trial: In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation (2003) (356)
- Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. (2007) (355)
- Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice (2005) (349)
- A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. (2005) (314)
- Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. (2002) (307)
- Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System (2008) (293)
- Transcatheter aortic valve replacement in bicuspid aortic valve disease. (2014) (280)
- Correlation of Device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. (2010) (263)
- First report on a human percutaneous transluminal implantation of a self‐expanding valve prosthesis for interventional treatment of aortic valve stenosis (2005) (260)
- Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: The first valve in valve procedure using the corevalve revalving system (2007) (232)
- 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. (2011) (218)
- Six- and Twelve-Month Results From First Human Experience Using Everolimus-Eluting Stents With Bioabsorbable Polymer (2004) (216)
- Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. (2011) (201)
- Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. (2012) (200)
- Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. (2013) (189)
- Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis (2008) (187)
- Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction After Paclitaxel-Eluting and Bare Metal Stent Implantation (2007) (186)
- Prevention of Distal Embolization During Coronary Angioplasty in Saphenous Vein Grafts and Native Vessels Using Porous Filter Protection (2001) (186)
- Emergency Polytetrafluoroethylene-Covered Stent Implantation to Treat Coronary Ruptures (2000) (185)
- Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. (2009) (177)
- Results of the Jostent coronary stent graft implantation in various clinical settings: Procedural and follow‐up results (2002) (170)
- Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. (2014) (169)
- A Bicuspid Aortic Valve Imaging Classification for the TAVR Era. (2016) (162)
- Incomplete Stent Apposition After Implantation of Paclitaxel-Eluting Stents or Bare Metal Stents: Insights From the Randomized TAXUS II Trial (2005) (158)
- First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. (2012) (149)
- “Device landing zone” calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI (2010) (149)
- Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. (2007) (140)
- Transaortic transcatheter aortic valve implantation: A novel approach for the truly “no‐access option” patients (2010) (139)
- Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study. (2017) (131)
- Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results (2005) (129)
- Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. (2012) (124)
- One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial). (2005) (121)
- Transcatheter aortic valve implantation: predictors of procedural success--the Siegburg-Bern experience. (2010) (119)
- Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. (1999) (118)
- Chronic Arterial Responses to Polymer-Controlled Paclitaxel-Eluting Stents: Comparison With Bare Metal Stents by Serial Intravascular Ultrasound Analyses: Data From the Randomized TAXUS-II Trial (2004) (118)
- Final 5-Year Results of the TAXUS II Trial: A Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for De Novo Coronary Artery Lesions (2009) (117)
- A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. (2003) (116)
- Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. (2008) (115)
- Balloon-Protected Carotid Artery Stenting: Relationship of Periprocedural Neurological Complications With the Size of Particulate Debris (2001) (115)
- Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial. (2015) (112)
- Novel Drug-Delivery Stent: Intravascular Ultrasound Observations From the First Human Experience With the QP2-Eluting Polymer Stent System (2001) (102)
- 7-Hexanoyltaxol–Eluting Stent for Prevention of Neointimal Growth: An Intravascular Ultrasound Analysis From the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE) (2002) (102)
- Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9 eluting stent with a biodegradable polymer coating. (2005) (101)
- [Percutaneous aortic valve replacement]. (2006) (101)
- Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation. (2012) (100)
- Heparin-Coated Stent Placement for the Treatment of Stenoses in Small Coronary Arteries of Symptomatic Patients (2003) (100)
- BioMatrix® Biolimus A9®-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease (2006) (98)
- Effectiveness and Safety of Sirolimus-Eluting Stents in the Treatment of Restenosis After Coronary Stent Placement (2005) (97)
- Comparison of one- and 12-month outcomes of transcatheter aortic valve replacement in patients with severely stenotic bicuspid versus tricuspid aortic valves (results from a multicenter registry). (2014) (96)
- Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). (2005) (94)
- Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. (2006) (89)
- Development of a risk score for outcome after transcatheter aortic valve implantation (2014) (87)
- Cognitive Trajectory After Transcatheter Aortic Valve Implantation (2013) (85)
- Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. (2004) (85)
- Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis (2008) (85)
- Outcomes and predictors of mortality after transcatheter aortic valve implantation: Results of the Brazilian registry (2015) (84)
- Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings. (2007) (83)
- Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. (2012) (83)
- High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial. (2004) (83)
- A multicentre evaluation of the safety of intracoronary optical coherence tomography. (2009) (82)
- Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions. (2008) (81)
- Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ (2008) (80)
- Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials). (2006) (78)
- Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. (2010) (77)
- Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound. (2002) (77)
- Five‐year long‐term clinical follow‐up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial (2010) (75)
- The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry. (2012) (71)
- Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions. (2006) (71)
- Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. (2002) (69)
- Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement. (2014) (68)
- Symetis ACURATE TF™ aortic bioprosthesis. (2013) (66)
- Network Analysis of Human In-Stent Restenosis (2006) (66)
- Effects of gold coating of coronary stents on neointimal proliferation following stent implantation. (2002) (65)
- An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. (2009) (64)
- Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. (2010) (64)
- Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program. (2011) (64)
- The SPIRIT V diabetic study: a randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions. (2012) (64)
- Chimney Stenting for Coronary Occlusion During TAVR: Insights From the Chimney Registry. (2020) (64)
- Laser angioplasty of restenosed coronary stents: results of a multicenter surveillance trial. The Laser Angioplasty of Restenosed Stents (LARS) Investigators. (1999) (62)
- TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. (2007) (62)
- TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions. (2009) (62)
- The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions. (2011) (60)
- Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial. (2016) (60)
- Intravascular Lithotripsy in Calcified Coronary Lesions: A Prospective, Observational, Multicenter Registry. (2019) (60)
- Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I). (2005) (58)
- Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (in-series) CoreValve prostheses in 1 procedure. (2010) (57)
- A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent. (2010) (55)
- Volume–outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK) (2007) (53)
- Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006. (2010) (53)
- Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: A multicenter prospective registry of 150 consecutive patients (2007) (52)
- Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions. (2011) (52)
- 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study. (2018) (51)
- Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. (2007) (50)
- Three-dimensional speckle-tracking analysis of left ventricular function after transcatheter aortic valve implantation. (2012) (50)
- Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy. (2004) (50)
- Initial multicenter experience with a novel distal protection filter during carotid artery stent implantation (2003) (50)
- Optical Coherence Tomography (OCT) (2003) (47)
- Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention (2002) (46)
- ABT-578-Eluting Stents (2004) (45)
- First-in-man (FIM) study of the Stentys bifurcation stent--30 days results. (2009) (45)
- Initial experience with paclitaxel-coated stents. (2002) (44)
- Effects of octreotide treatment on restenosis after coronary angioplasty: results of the VERAS study. VErringerung der Restenoserate nach Angioplastie durch ein Somatostatin-analogon. (1997) (44)
- The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation (2013) (44)
- Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. (2005) (44)
- Images in cardiovascular medicine. Intracoronary imaging with optical coherence tomography: a new high-resolution technology providing striking visualization in the coronary artery. (2002) (44)
- Acute and long‐term outcomes of the novel side access (SLK‐View™) stent for bifurcation coronary lesions: A multicenter nonrandomized feasibility study (2006) (44)
- Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. (2015) (43)
- Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses: a multicentre propensity score analysis. (2017) (43)
- Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions. (2008) (42)
- Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre "CE-approval cohort". (2017) (42)
- Direct Transcatheter Heart Valve Implantation Versus Implantation With Balloon Predilatation: Insights From the Brazilian Transcatheter Aortic Valve Replacement Registry (2016) (41)
- Rapamycin Analogs for Stent-Based Local Drug Delivery (2004) (40)
- The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation. (2016) (40)
- High-frequency mechanical vibration to recanalize chronic total occlusions after failure to cross with conventional guidewires. (2006) (39)
- Tryton I, First-In-Man (FIM) Study: acute and 30 day outcome.A preliminary report. (2007) (38)
- Drug eluting stents: initial experiences (2002) (37)
- Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial. (2019) (37)
- Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study. (2007) (37)
- Analysis of left main coronary artery bifurcation lesions treated with biolimus‐eluting DEVAX AXXESS plus nitinol self‐expanding stent: Intravascular ultrasound results of the AXXENT trial (2009) (36)
- Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study. (2016) (36)
- Treatment of a degenerative stenosed CoreValve® aortic bioprosthesis by transcatheter valve‐in‐valve insertion (2012) (34)
- Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry). (2008) (34)
- First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent. (2010) (33)
- Serial intravascular ultrasound analysis of bifurcation lesions treated using the novel self-expanding sideguard side branch stent. (2009) (33)
- Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial). (2007) (33)
- Coronary Protection to Prevent Coronary Obstruction During TAVR (2020) (33)
- Direct Stenting with TAXUS Stents Seems to be as Safe and Effective as with Predilatation (2004) (33)
- Percutaneous Recanalization of Chronically Occluded Coronary Arteries A New Drugs and Technologies (2005) (33)
- Sodium intake modulates left ventricular hypertrophy in essential hypertension (1988) (33)
- Prognostic value of cerebral injury following transfemoral aortic valve implantation. (2013) (32)
- In-hospital outcomes after elective and non-elective percutaneous coronary interventions in hospitals with and without on-site cardiac surgery backup (2009) (31)
- A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. (2008) (31)
- Pre-Procedural Hemodynamic Status Improves the Discriminatory Value of the Aortic Regurgitation Index in Patients Undergoing Transcatheter Aortic Valve Replacement. (2016) (31)
- Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial (2019) (30)
- Everolimus for stent-based intracoronary applications. (2004) (30)
- Next-generation transcatheter heart valves: current trials in Europe and the USA. (2012) (30)
- Medtronic CoreValve Evolut R with EnVeo R. (2013) (28)
- Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry. (2007) (28)
- Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation (2016) (28)
- Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR (2015) (27)
- Analysis of bifurcation lesions treated with novel drug‐eluting dedicated bifurcation stent system: Intravascular ultrasound results of the AXXESS PLUS trial (2007) (27)
- MOONLIGHT: a controlled registry of an iridium oxide-coated stent with angiographic follow-up. (2004) (27)
- Determinants of mortality after cardiac surgery: results of the registry of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) on 10 525 patients. (2000) (27)
- Coronary stenting with MGuard: first-in-man trial. (2008) (27)
- Periprocedural Myocardial Injury Depends on Transcatheter Heart Valve Type But Does Not Predict Mortality in Patients After Transcatheter Aortic Valve Replacement. (2017) (27)
- First clinical experience with Celt ACD(®) : a femoral arterial puncture closure device. (2013) (27)
- Outcome Self-Expanding CoreValve Prosthesis: Device Success and 30-Day Clinical High-Risk Patients Using the Second- and Current Third-Generation Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in (2007) (26)
- Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation. (2017) (26)
- First-in-man transapical mitral valve replacement using the Direct Flow Medical® aortic valve prosthesis. (2015) (26)
- Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies (2013) (26)
- An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial program. (2006) (25)
- Intracoronary Imaging With Optical Coherence Tomography (2002) (25)
- Medtronic CoreValve Evolut valve. (2012) (24)
- Doppler-based renal resistance index for the detection of acute kidney injury and the non-invasive evaluation of paravalvular aortic regurgitation after transcatheter aortic valve implantation. (2014) (24)
- The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions). (2014) (23)
- Polymer‐based paclitaxel‐eluting stent for treatment of chronic total occlusions of native coronaries: Results of a Taxus CTO registry (2005) (22)
- Transcatheter aortic valve implantation: the evidence (2012) (22)
- Clinical experiences using everolimus-eluting stents in patients with coronary artery disease. (2004) (22)
- Influence of plaque calcium on neointimal hyperplasia following bare metal and drug‐eluting stent implantation (2006) (22)
- Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study. (2006) (21)
- Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI). (2007) (21)
- Left main PCI after trans-subclavian CoreValve implantation. Successful outcome of a combined procedure for management of a rare complication (2009) (21)
- One-year outcomes after direct transcatheter aortic valve implantation with a self-expanding bioprosthesis. A two-center international experience. (2016) (21)
- Non-invasive diagnosis of a false left ventricular aneurysm by echocardiography and pulsed Doppler echocardiography. (1980) (21)
- Direct Flow Medical valve. (2012) (21)
- Hydrodynamic Performance of the Medtronic CoreValve and the Edwards SAPIEN XT Transcatheter Heart Valve in Surgical Bioprostheses: An In Vitro Valve-in-Valve Model. (2016) (20)
- Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI (2013) (20)
- Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation. (2017) (20)
- Effect of prolonged thienopyridine use after drug-eluting stent implantation (from the TAXUS landmark trials data). (2008) (20)
- The "Big Five" Complications After Transcatheter Aortic Valve Replacement: Do We Still Have to Be Afraid of Them? (2019) (19)
- Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments. (2006) (19)
- Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial. (2010) (19)
- Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humans☆ (1980) (19)
- Relation of hemodynamic reaction during stress to left ventricular hypertrophy in essential hypertension. (1990) (19)
- Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR. (2020) (19)
- Transcatheter Annuloplasty for Mitral Regurgitation with an Adjustable Semi-Rigid Complete Ring: Initial Experience with the Millipede IRIS Device (2018) (19)
- SCOREO trial interim safety results: despite efficacy, late stent thrombosis with the QuaDDS-QP2 stent (2002) (18)
- One year results of a new in situ length-adjustable stent platform with a biodegradable biolimus A9 eluting polymer: results of the CUSTOM-II trial. (2008) (18)
- Randomized, double‐blind, multicenter study of the polymer‐based 17‐β estradiol‐eluting stent for treatment of native coronary artery lesions: Six‐month results of the ETHOS I trial (2007) (18)
- Impact of In-Stent Minimal Lumen Area at 9 Months Poststent Implantation on 3-Year Target Lesion Revascularization–Free Survival: A Serial Intravascular Ultrasound Analysis From the TAXUS IV, V, and VI Trials (2008) (18)
- Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation: results from the German multicenter registry. (2012) (18)
- Subacute Subclinical Brain Infarctions after Transcatheter Aortic Valve Implantation Negatively Impact Cognitive Function in Long-Term Follow-Up (2017) (18)
- Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus. (2008) (17)
- [Demonstration of left-ventricular contraction anomalies with the two-dimensional sector-scanner (author's transl)]. (1979) (17)
- An exceptional case of frame underexpansion with a self-expandable transcatheter heart valve despite predilation. (2012) (17)
- Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in‐tunnel PFO closure: Results of the Coherex‐EU study (2014) (17)
- Paclitaxel-Eluting Stents (2004) (17)
- Validation of a thermographic guidewire for endoluminal mapping of atherosclerotic disease: An in vitro study (2004) (16)
- [Modification of myocardial function parameters by L- and D-penbutolol--an echocardiography, placebo-controlled double-blind study]. (1985) (16)
- Balloon post-dilation and valve-in-valve implantation for the reduction of paravalvular leakage with use of the self-expanding CoreValve prosthesis. (2016) (16)
- A clinical protocol for analysis of the structural integrity of the Medtronic CoreValve System frame and its application in patients with 1-year minimum follow-up. (2010) (16)
- A method for standardized computed tomography angiography-based measurement of aortic valvar structures. (2010) (16)
- Coronary stenting with MGuard: extended follow-up of first human trial. (2011) (15)
- Prevalence and Impact of Sleep Disordered Breathing in Patients with Severe Aortic Stenosis (2015) (15)
- First-In-Man application of a miniature self-contained intracoronary magnetic resonance probe. A multi-centre safety and feasibility trial. (2006) (15)
- Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry. (2020) (15)
- Drug-eluting stents: clinical experiences and perspectives. (2002) (15)
- Automatic Contour Finding and Digital Subtraction Technique in 2-Dimensional Echocardiography (1987) (15)
- Pharmacokinetic and Pharmacodynamic Properties of Ramipril in Patients with Congestive Heart Failure (NYHA III‐IV) (1989) (15)
- Opportunistic Computed Tomography Imaging for the Assessment of Fatty Muscle Fraction Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement. (2020) (14)
- [Percutaneous suture of femoral artery access sites after diagnostic heart catheterization and or coronary intervention. Safety and effectiveness of a new arterial suture technic]. (1998) (14)
- Permanent Pacemaker Implantation after TAVR - Predictors and Impact on Outcomes. (2015) (14)
- Early Insight into Mitralign Direct Annuloplasty for Treatment of Functional Mitral Regurgitation (2011) (14)
- Computerized two-lead resting ECG analysis for the detection of coronary artery stenosis (2007) (14)
- Potential of a New High-Resolution Intracoronary Imaging Technique (2003) (14)
- Mechanisms of lumen narrowing of saphenous vein bypass grafts 12 months after implantation: An intravascular ultrasound study (2006) (14)
- Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials. (2010) (14)
- Computerized two-lead resting ECG analysis for the detection of coronary artery stenosis after coronary revascularization (2008) (14)
- Outcome in TAVI patients with symptomatic aortic stenosis not fulfilling PARTNER study inclusion criteria (2015) (13)
- Percutaneous aortic valve replacement for the treatment of aortic stenosis: early experience in Brazil. (2009) (13)
- Final report of the European multi-center registry using the Deutt™ vascular sealing device (1999) (13)
- Complete percutaneous approach versus surgical access in transfemoral transcatheter aortic valve implantation: results from a multicentre registry. (2018) (13)
- Caval Valve Implantation for Treatment of Severe Tricuspid Regurgitation. (2018) (13)
- Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index) (2019) (13)
- Predictors of Permanent Pacemaker Insertion Following Transcatheter Aortic Valve Replacement With the CoreValve Revalving System Based on Computed Tomography Analysis: An Asian Multicenter Registry Study. (2014) (13)
- Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: The Rinspiration international registry (2008) (13)
- Treatment of uncrossable chronic total coronary occlusions with the frontrunner: multicenter experience (2002) (12)
- Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials. (2008) (12)
- [Improving color Doppler echocardiography of the right heart chambers following intravenous injection of SHU 454]. (1988) (12)
- [Percutaneous suture closure of the femoral artery access after diagnostic heart catheter examination or coronary intervention]. (2008) (12)
- CoreValve degeneration with severe transvalvular aortic regurgitation treated with valve-in-valve implantation. (2014) (12)
- Thirty-day Clinical Outcomes of the Evolut PRO Self-Expanding Transcatheter Aortic Valve: The International FORWARD PRO Study. (2020) (12)
- Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents. (2007) (12)
- A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus‐ vs. Paclitaxel‐eluting stents in de novo occlusive lesions in coronary arteries: Five‐year results from the ZOMAXX I trial (2013) (11)
- Catheter-Based Edge-to-Edge Mitral Valve Repair After Partial Rupture of Surgical Annuloplasty Ring. (2015) (11)
- SCORE six-month angiographic results: improved restenosis in patients receiving the QUADDS-QP2 drug-eluting stent compared with the control, bare stents (2002) (11)
- Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results. (2008) (11)
- Two‐year outcomes after deployment of XIENCE V everolimus‐eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: A report from the SPIRIT V single arm study (2013) (11)
- Evaluation of a tarcolimus-eluting coronary stent with nanoporous ceramic coating in treatment of native coronary artery lesions: Phase I and II of the PRESENT study (2003) (11)
- Transcatheter valve implantation improves central sleep apnoea in severe aortic stenosis. (2013) (11)
- Mechanisms of lumen narrowing of saphenous vein bypass grafts 12 months after implantation: an intravascular ultrasound study. (2002) (10)
- Percutaneous transluminal coronary angioplasty of left main stenosis – results of the German PTCA registry (2000) (10)
- THE BOSTON SCIENTIFIC ANTIPROLIFERATIVE , PACLITAXEL ELUTING STENTS ( TAXUS ) (2001) (10)
- Incidental finding of a papillary fibroelastoma on the aortic valve in 16 slice multi-detector row computed tomography (2004) (10)
- The new coronary stent Graft JoStent®: first clinical experience (1998) (10)
- [Automatic contour detection in the 2-dimensional echocardiogram--studies in a general patient population]. (1985) (10)
- First-in-man assessment of the InSeal VCD, a novel closure device for large puncture accesses. (2015) (10)
- Novel approaches for prevention of stroke related to transcatheter aortic valve implantation (2013) (10)
- Three-dimensional imaging of the aortic valve geometry for prosthesis sizing prior to transcatheter aortic valve replacement. (2014) (9)
- A permanent solution for a temporary problem: transcatheter valve-in-valve implantation for failed transcatheter aortic valve replacement. (2012) (9)
- Transcatheter aortic valve implantation through a diseased left common carotid artery: Combined approach with endarterectomy and left carotid‐subclavian bypass (2013) (9)
- The Quanam QuaDDS-QP2 Stent (2001) (9)
- [Automatic and semiautomatic contour finding of the left ventricle in the 2 dimensional echocardiogram. In vitro studies in formalin-fixed swine hearts]. (1985) (9)
- Coronary stents: In vitro aspects of an angiographic and ultrasound quantification with in vivo correlation. (1998) (9)
- [Assessment of the severity of mitral valve insufficiency using color Doppler echocardiography]. (1989) (9)
- Impact of Drug-Eluting Stents on Distal Vessels (2012) (9)
- Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients (2020) (9)
- Advances in percutaneous treatment for adult valvular heart disease (2009) (9)
- First experience with the Impella Recover(R) LP 2.5 micro axial pump in patients with cardiogenic shock or undergoing high-risk revascularisation. (2006) (9)
- TCT-46 Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-In-Man Trial (2012) (9)
- Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting (2012) (8)
- Safety and performance of a paclitaxel-eluting stent for the treatment of in-stent restenosis: preliminary results of the taxus III trial (2002) (8)
- CD-144 positive endothelial microparticles are increased in patients with systemic inflammatory response syndrome after TAVI. (2016) (8)
- TCT-107 Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes from the SURTAVI Trial (2017) (8)
- First human experience using a new everolimus stent coating: Procedural and six-month follow-up results of the FUTURE trial (2003) (8)
- Current Concepts in the Treatment of Cardiac Arrhythmias (1986) (8)
- Challenges in transcatheter valve treatment: aortic regurgitation after transcatheter aortic valve implantation. (2013) (8)
- [Determinants for myocardial hypertrophy in mild essential hypertension. The effect of sodium chloride on left-ventricular hypertrophy]. (1990) (8)
- Early experience with a novel plaque excision system for the treatment of complex coronary lesions (2004) (8)
- Paclitaxel-eluting stents: current clinical experience. (2004) (8)
- Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. (2022) (8)
- The development of door-to-angiography time in the last 14 years for patients with acute ST-elevation myocardial infarction treated with primary coronary intervention: Determinants and outcome. Results from the MITRAplus and OPTAMI registry (2011) (8)
- STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: LONG-TERM RESULTS AFTER 6 YEARS OF THE WATCHMAN LEFT ATRIAL APPENDAGE OCCLUSION PILOT STUDY (2011) (8)
- Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry) (2010) (8)
- Four-year experience with the CoreValve transcatheter heart valve. (2016) (7)
- FX MiniRAIL catheter usage for treatment of de novo complex coronary lesions: results from the "OFFAR". (2006) (7)
- Appraising the effectiveness and safety of paclitaxel-eluting stents in over 1,000 very high-risk patients: overall results of the Taxus in Real-life Usage Evaluation (TRUE) registry. (2007) (7)
- Innovations and novel technologies in TAVI. Second generation transcatheter heart valves. (2013) (7)
- [Computer assisted determination of left-ventricular contraction abnormalities using two-dimensional echocardiography. I. Analysis various study methods and determination of normal values]. (1984) (7)
- Impact of Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement. (2020) (7)
- Percutaneous suturing of femoral artery access sites after diagnostic cardiac catheterization or coronary intervention (1997) (7)
- Pharmacokinetics and pharmacodynamics of intravenous digoxin and digitoxin (1981) (7)
- [Brugada syndrome or ARVD (arrhythmogenic right ventricular dysplasia) or both? Significance and value of right precordial ECG changes]. (2002) (7)
- Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system. (2015) (7)
- The Lunar Stent (2002) (7)
- Fractional flow reserve in patients with coronary artery disease undergoing TAVI: a prospective analysis (2019) (7)
- Combination of high-sensitivity C-reactive protein with logistic EuroSCORE improves risk stratification in patients undergoing TAVI. (2018) (6)
- Kinetics and cardiac effects of propranolol in humans (1982) (6)
- Evaluation of a new polymer-coated paclitaxel-eluting stent for treatment of de novo lesions: six-month clinical and angiographic follow-up results of the APPLAUSE trial. (2006) (6)
- Impact of Hemodynamic Support on Outcome in Patients Undergoing High-Risk Percutaneous Coronary Intervention. (2019) (6)
- The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic). (2009) (6)
- [Fast computer tomography for investigation of the heart--"computer cardiotomography". Methods and early results (author's transl)]. (1978) (6)
- Experience with CoreValve aortic valve replacement in patients for surgical aortic valve replacement (2008) (6)
- Transcatheter Aortic Valve Implantation: Upcoming New Devices. (2012) (6)
- Treatment of In-Stent restenosis using a stent with non-polymer-based paclitaxel elution. (2004) (6)
- Direct stent implantation using the EXPRESS Coronary Stent System: results of a multi-center feasibility study. (2003) (6)
- Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography (2005) (6)
- Predictive factors and long-term prognosis of transcatheter aortic valve implantation-associated endocarditis (2020) (6)
- Saphenous vein graft stenting using a novel filter device for distal protection. (2003) (6)
- Use of Taxus polymer‐coated paclitaxel‐eluting stents for treatment of in‐stent restenosis in real world patients: Results of clinical and angiographic follow‐up at six months in a single‐center registry (2006) (6)
- [Determination of the severity of mitral stenosis by hemodynamic and echocardiographic parameters]. (1978) (5)
- Evaluation of the XIENCE V everolimus eluting coronary stent system in the Asian population of the SPIRIT V single arm study. 2-year clinical follow-up data. (2011) (5)
- 843-2 Everolimus-eluting stents for the prevention of restenosis: Results of the FUTURE II trial (2004) (5)
- [Improved reproducibility of contrast echocardiography by SH U 454. Experimental studies using digital subtraction echocardiography]. (1986) (5)
- Predictive Value of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Replacement (2019) (5)
- Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis. (2015) (5)
- TAVR outcome after reclassification of aortic valve stenosis by using a hybrid continuity equation that combines computed tomography and echocardiography data (2020) (5)
- Prognostic value of cerebral injury following transfemoral aortic valve implantation. (2012) (5)
- [Computer tomographic diagnosis of cardiac, pericardial and paracardial space occupying lesions]. (1981) (5)
- [Percutaneous aortic valve replacement - pro]. (2009) (5)
- Clinical and angiographic performance of a new‐generation modular stent design for treatment of de novo coronary lesions (2001) (5)
- Intravenous quinidine: pharmacokinetic properties and effects on left ventricular performance in humans. (1981) (5)
- Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial. (2005) (5)
- The CoreValve in the aortic position (2006) (5)
- [State of treatment of coronary artery disease by drug releasing stents]. (2002) (5)
- 1495 Everolimus stent coating: promising procedural and 6-month angiographic and intravascular ultrasound follow-up results of the FUTURE I and II trial (2003) (5)
- Transcatheter aortic valve implantation and closure of the left atrial appendage under cerebral protection. (2012) (5)
- Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials. (2014) (5)
- Substitution of ethanol with specially designed microspheres in a TASH procedure. (2011) (5)
- Intraoperative cell-cycle blockade therapy using E2F decoy for prevention of early atherosclerosis in coronary bypass vein grafts: a volumetric IVUS subanalysis from a prospective randomized double blind clinical trial (2002) (4)
- High-Frequency Annular Array Transesophageal Probe for High-Resolution Imaging and Continuous Wave Doppler Measurements (1989) (4)
- [Evaluation of aortic valve insufficiency using color Doppler echocardiography]. (1987) (4)
- Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry). (2010) (4)
- DE NOVO CORONARY LESIONS TREATED WITH THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS: 12-MONTH ANGIOGRAPHIC RESULTS FROM THE PROSPECTIVE RANDOMIZED MULTICENTER BIOFREEDOM CLINICAL TRIAL (2011) (4)
- [Clinical experiences with the PercuSurge GuardWire--a new system for prevention of peripheral embolisms in catheter interventions on degenerated coronary artery venous bypasses]. (2000) (4)
- Optical coherence tomography imaging of thrombus protrusion through stent struts after stenting in acute coronary syndrome (2005) (4)
- Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary artery. (2009) (4)
- Drug-Eluting Stents in the Treatment of Intermediate Lesions (2006) (4)
- Effects of the QUADDS-QP2 drug-eluting stent extend beyond the targeted area into adjacent nonstented zones: results of the SCORE trial (2002) (4)
- The Medtronic transcatheter mitral valve implantation system. (2015) (4)
- [Quantitative, computer-aided determination of left ventricular contraction abnormalities in two-dimensional echocardiography. II. Application in patients with coronary heart disease]. (1984) (4)
- 1044-56 Paclitaxel-eluting stent in complicated lesions or patient subsets: A subanalysis from the TAXUS II study (2004) (4)
- [Fungal endocarditis of the tricuspid valve in Crohn disease]. (1987) (4)
- Frailty, malnutrition, and the endocrine system impact outcome in patients undergoing aortic valve replacement (2021) (3)
- Use of Pre- and Intensified Postprocedural Physiotherapy in Patients with Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Study (the 4P-TAVR Study) (2021) (3)
- Subclavian Access for Transcatheter CoreValve ® Aortic Prosthesis Implantation: Data from the Brazilian Registry (2012) (3)
- [Temporal trends in the use of drug-eluting stents in German clinical practice]. (2008) (3)
- [A rare pacemaker complication of a perforation by a ventricular screw electrode causing hemothorax]. (1986) (3)
- Impact of Coronary Artery Disease on Outcomes in Patients Undergoing Percutaneous Edge-to-Edge Repair. (2020) (3)
- Efficacy and feasibility of helixcision for debulking neointimal hyperplasia for in‐stent restenosis (2002) (3)
- Prospective non-randomized multi-centre evaluation of the non-polymer based ACHIEVE Paclitaxel Eluting Coronary Stent System in treatment of lesions with high risk of revascularization due to restenosis: the DELIVER II study. (2006) (3)
- Initial and follow-up results of the European Seaquence coronary stent registry. (2004) (3)
- [Echocontrast ventriculography. Determination of left ventricular functional parameters with special reference to digital subtraction echocardiography]. (1986) (3)
- Predictors of 30-day Mortality after Transcatheter Aortic Valve Implantation - Results from the Expanded Evaluation Registry with the 3rd Generation CoreValve ReValving System (2009) (3)
- Impact of coronary artery disease on in-hospital mortality in patients with aortic valve disease (2013) (3)
- Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy. (2013) (3)
- Images in cardiology. Optical coherence tomography imaging of thrombus protrusion through stent struts after stenting in acute coronary syndrome. (2006) (3)
- Trans-catheter percutaneous aortic valve implantation for severe inoperable aortic valve stenosis: where do we stand? (2010) (3)
- Intravenous quinidine in congestive cardiomyopathy (1981) (3)
- Local intra-renal fenoldopam infusion causes greater increases in renal artery flow velocity than systemic intravenous fenoldopam infusion: a pilot study. (2005) (3)
- 1059-6 The multicenter evaluation of the everolimus-eluting stent for inhibition of neointimal hyperplasia: Results of the pooled FUTURE I and II trials (2004) (3)
- Antegrade transcatheter mitral valve-in-valve implantation with combined atrial septal defect closure (2016) (3)
- Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials). (2008) (3)
- Computertomographische Diagnostik des Perikardergusses (1979) (2)
- TCTAP A-161 Comparison of Next Generation Transcatheter Heart Valves: Angiographic, Echocardiographic and Hemodynamic Evaluation of an Extended All-comers Study Cohort Using the Dimensionless Aortic Regurgitation Index (2017) (2)
- Impact of preoperative mitral regurgitation on outcome after Transcatheter Aortic Valve Implantation: results of the German TAVI registry (2013) (2)
- Mitralign Percutaneous Annuloplasty System for the Treatment of Functional Mitral Regurgitation (2010) (2)
- [Position paper on the use of drug eluting stents in coronary heart disease]. (2004) (2)
- [Determination of left ventricular global ejection fraction using ECG-gated cardiac computed tomography]. (1985) (2)
- How should I treat a patient with a stenosed bicuspid aortic valve and an unexpected finding during TAVI? (2014) (2)
- About the use of the ACHIEVE paclitaxel eluting stent in treatment of restenotic lesions: A subanalysis of the 30-day safety data of DELIVER II (2003) (2)
- OCT findings in drug-eluting stents (2007) (2)
- Serial intravascular ultrasound observations from the Tryton first-in-man study. (2014) (2)
- The Justified Revival of a Well-known Technique (2009) (2)
- Successful post-dilation of a Lotus transcatheter aortic valve in a case of prosthesis frame underexpansion due to leaflet calcification. (2015) (2)
- Transcatheter heart valve failure: the sword of Damocles over our heads? (2015) (2)
- [Accuracy of cardiac CT and echocardiography in the diagnosis of space-occupying processes in the heart]. (1986) (2)
- RISK SCORES AND BIOMARKERS FOR THE PREDICTION OF 1-YEAR OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2015) (2)
- The Boston Scientific Antiproliferative, Paclitaxel Eluting Stents (TAXUS) (2001) (2)
- Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR—A multicenter experience (2022) (2)
- Three-dimensional IVUS assessment of edge effects following drug-eluting stent implantation (2002) (2)
- Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation (2022) (2)
- The 9-month results of the TROPICAL study: A multicenter nonrandomized study of the cypher sirolimus-eluting stent in the treatment of patients with an in-stent restenotic native coronary artery lesion (2004) (2)
- Final 3‐year clinical outcomes following transcatheter aortic valve implantation with a supra‐annular self‐expanding repositionable valve in a real‐world setting: Results from the multicenter FORWARD study (2021) (2)
- Percutaneous trans-axilla transcatheter aortic valve replacement (2022) (2)
- O renascimento justificado de uma técnica bem conhecida (2009) (2)
- Mini-Focus: Aortic Valve DiseaseEditorial CommentUnbreak My Heart (Valve): Can Ultrasound Be Used for the Treatment of a Degenerated Surgical Bioprosthesis?∗ (2017) (1)
- [Cyanotic patient with right ventricular dilatation and ventricular arrhythmias]. (1987) (1)
- Elective Coronary Stenting as an Adjunct to Balloon Angioplasty in Stable Coronary Artery Disease: No Association with Incidence of Acute Complications. Results of the PTCA Registry of the German Community Hospitals (2000) (1)
- Der perkutane Aortenklappenersatz - ein Update (2008) (1)
- Incidence, predictors, and prognostic value of periprocedural myocardial injury after TAVI (2013) (1)
- Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry. (2023) (1)
- DIRECT TRANSCATHETER AORTIC VALVE REPLACEMENT VERSUS IMPLANTATION WITH BALLOON PREDILATATION: INSIGHTS FROM THE BRAZILIAN TAVR REGISTRY (2016) (1)
- Indoramin in Severe Congestive Heart Failure (1986) (1)
- New Alternative in Embolic Protection The Mesh Covered MGuard Stent (2007) (1)
- COMPARISON OF PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION WITH AND WITHOUT BALLOON AORTIC PREDILATATION. IN-HOSPITAL AND LONG-TERM MORTALITY (2015) (1)
- Valvular Heart Disease Aortic Regurgitation Index Defines Severity of Peri-Prosthetic Regurgitation and Predicts Outcome in Patients After Transcatheter Aortic Valve Implantation (2012) (1)
- P918Tricuspid regurgitation in patients undergoing transcatheter aortic valve implantation (2019) (1)
- TRANS-AORTIC IMPLANTATION OF THE MEDTRONIC COREVALVE PROSTHESIS. SUCCESSFUL IMPLANTATION THROUGH AN ALTERNATIVE ACCESS ROUTE (2010) (1)
- [Intestinal absorption and metabolism of lanatoside C]. (1978) (1)
- [Optical coherence tomography imaging in coronary drug-eluting stenting]. (2005) (1)
- Very Long Term Clinical Outcomes of Patients with Coronary Bifurcation Lesions Treated with the Biolimus A9 Coated Dedicated Axxess Stent: Results from the Prospective, Multicenter AXXESS Plus Trial (Final Report of the Study) (2011) (1)
- Helical atheractomy for in-stent restenosis: acute and long-term results from the helixcision™ endoluminal in-stent excision (HELIX 1) international feasibility trial (2002) (1)
- COMPARISON OF TRANSFEMORAL AND TRANSAPICAL AORTIC VALVE REPLACEMENT: RESULTS OF THE GERMAN REGISTRY ON TRANSCATHETER AORTIC VALVE IMPLANTATIONS (2010) (1)
- [Clinical and haemodynamic results with intra-aortic counterpulsation (author's transl)]. (1975) (1)
- Abstract 13496: Aortic Regurgitation Index Defines Severity of Periprosthetic Regurgitation and Predicts Outcome in Patients after Tavi: A Two-Centre Experience (2012) (1)
- Development of a risk score predicting 1-year mortality after transcatheter aortic valve implantation (2014) (1)
- A Bicuspid Aortic Valve Imaging Classi fi cation for the TAVR Era (2016) (1)
- Transcatheter bioprosthesis implantation for the treatment of aortic stenosis: three-year experience. (2012) (1)
- TCT-14 Very Long-term Results of BioFreedom First-In-Man, a Randomized Trial comparing Polymer-Free BioFreedom(tm) stents with Durable Polymer Taxus Liberté(tm) Stents (2013) (1)
- Optimal endpoint for drug-eluting stent: predictive value of minimum stent area for long-term stent patency (2002) (1)
- Two sides to every story: the trade-off between paravalvular leakage and the occurrence of conduction disturbances in transcatheter heart valves. (2017) (1)
- The lunar stent characteristics and clinical results. (2002) (1)
- First-in-man experience of percutaneous aortic valve replacement using self-expanding corevalve prosthesis. (2011) (1)
- INCIDENCE OF ACUTE KIDNEY INJURY WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE BRAVO-3 RANDOMIZED TRIAL (2017) (1)
- [Background and indications for distal protection devices in percutaneous coronary interventions]. (2006) (1)
- The Boston Scientific paclitaxel eluting stent: TAXUS I and II (2005) (1)
- Prospective evaluation of the aortic regurgitation index in TAVI patients (2013) (1)
- [Intraoperative measurement of velocity and volume of coronary circulation using the Duplex system]. (1988) (1)
- Transcatheter Triple-Valve Intervention. (2021) (1)
- THE QUANAM QUADDS-QP 2 STENT (2001) (1)
- Transcatheter aortic valve implantation in nonagenarians - old…but not obsolete! (2020) (0)
- Abstract 19332: Results of Transfemoral Transcatheter Aortic Valve Implantation in Partner-Like Patients - A Comparison with Real-World Patients - The Bonn-Essen Experience (2012) (0)
- Abstract 1741: Predicting Coronary Stenosis by Computer-Enhanced, Resting Electrocardiogram: Effect of Gender, Age, and Revascularization on Sensitivity and Specificity (2007) (0)
- P973Intravascular lithotripsy for lesion preparation in calcified coronary lesions: a prospective, observational, two-center registry (2019) (0)
- SIX YEARS OPTICAL COHERENCE TOMOGRAPHY, INTRAVASCULAR ULTRASOUND, AND QUANTITATIVE CORONARY ANGIOGRAPHY FOLLOW-UP OF PATIENTS WITH CORONARY LESIONS TREATED WITH THE BIOLIMUS A9-ELUTING STENTS WITH A BIOABSORBABLE POLYMER (2010) (0)
- Transcatheter aortic valve replacement: many roads lead to Rome...but the implantation technique makes the difference! (2013) (0)
- TCTAP A-118 12 Months Results from a CE Mark Trial of a 2nd Generation, Self-Expanding, Transfemoral Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis (2015) (0)
- The Quanam drug-eluting stent and the SCORE trial (2005) (0)
- Long-term effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement: 3-year results of the TROPICAL study (2006) (0)
- OUTCOME OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN OCTOGENARIANS IN COMPARISON TO YOUNGER PATIENTS: RESULTS OF THE GERMAN REGISTRY ON TRANSCATHETER AORTIC VALVE IMPLANTATIONS (2010) (0)
- P3723Impact of frailty status on 30-day mortality in patients with valvular heart disease undergoing percutaneous transcatheter valve interventions (2019) (0)
- Simplify TAVR?: To Pre-Dilate, or Not to Pre-Dilate, That Is the Question. (2020) (0)
- Why not "Simplify" TAVI? (2012) (0)
- Peripheral perfusion of lower limb after transcatheter aortic valve implantation (TAVI) in patients with peripheral artery disease. (2019) (0)
- 1139-60 An intravascular ultrasound analysis from FUTURE I, the first human experience using everolimus-eluting stents: Six- and 12-month results (2004) (0)
- PTA of a renal artery stenosis with a new embolization protection device: Evidence of side-branch occlusion due to distal embolization — A case report (2011) (0)
- [Therapy of supraventricular reentry tachycardia by implantation of a demand-regulated overdrive pacemaker]. (1977) (0)
- Intolerance of TEE probe Pulmonary complications Bronchospasm Hypoxia Cardiac complications Nonsustained ventricular tachycardia Transient atrial fibrillation Third-degree atrioventricular block Severe angina pectoris Bleeding complications Minor pharyngeal bleeding (2005) (0)
- Transcatheter Aortic Valve Replacement in Patients at High Risk of Coronary Obstruction (2022) (0)
- Impact of transradial versus transfemoral access for preprocedural coronary angiography on TAVR-associated complications (2023) (0)
- Clinical outcomes in treatment of chronic total occlusions with the XIENCE V everolimus-eluting stent system in real-world patients: one-year pooled results from the XIENCE V USA and SPIRIT V studies (2013) (0)
- Percutaneous transluminal aortic valve replacement: The CoreValve prosthesis (2010) (0)
- Abstract 2640: Long-Term Clinical Follow-up of Patients with De Novo Coronary Bifurcation Lesions Treated with the Nitinol Self-Expanding Biolimus A9-Eluting "AXXESS" Stent - Results from the Prospective, Multicenter Axxess Plus Trial (2006) (0)
- [Significance of microproteinuria for early detection of hypertension-induced end organ damage]. (1990) (0)
- Abstract 4434: 12 Months and Beyond: Long-Term Results of the Direct Flow Medical Repositionable and Retrievable Pericardial Valve for Percutaneous Aortic Valve Replacement (2009) (0)
- Impact of Device Landing Zone Calcification in Transcatheter Aortic Valve Implantation – The Device Landing Zone Calcification Score (2010) (0)
- Dangas bivalirudin heparin TAVR BRAVO 3 appendix JACC 12 2015 (2015) (0)
- Abstract 2833: Safety and Efficacy of Multiple, Overlapping Polymer-Based Paclitaxel-eluting Stents (2006) (0)
- Everolimus-eluting stents (2005) (0)
- The Use of Two-dimensional Sector Echocardiography in the Diagnosis of Coronary Heart Disease (1980) (0)
- Renal function after transcatheter aortic valve implantation (2013) (0)
- TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH BICUSPID AORTIC VALVE STENOSIS UTILIZING THE NEXT GENERATION FULLY RETRIEVABLE AND REPOSITIONABLE VALVE SYSTEM: EARLY RESULTS FROM THE MULTICENTER POL-TAVI REGISTRY (2017) (0)
- The Sideguard Side Branch Stent (2012) (0)
- Combined transcatheter aortic valve replacement and left atrial appendage occlusion in patients ineligible for oral anticoagulation: A case series. (2022) (0)
- Guidant deliver II study: prospective, nonrandomized, multicenter evaluation o fthe ACHIEVE™ paclitaxel-eluting coronary stent system in the treatment of lesions with high risk of revascularization due to restenosis (2005) (0)
- TCT-141 C-Reactive Protein/Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement (2019) (0)
- [Intra-aortic adverse pulsation]. (1978) (0)
- Next generation of drug eluting stents'Sirolimus-analogues'. (2005) (0)
- [Cardiomyopathy in progressive muscular dystrophy]. (1990) (0)
- Paclitaxel Incorporated in a Slow-Release Polymer Formulation TAXUS III Trial : In-Stent Restenosis Treated With Stent-Based Delivery of (2003) (0)
- [Computer tomographic diagnosis of pericardial effusions (author's transl)]. (1979) (0)
- Intravascular ultrasound analysis of sirolimus-eluting stents for the treatment of in-stent restenosis: Results from the TROPICAL trial (2005) (0)
- Gut Microbiota Signature in Heart Failure Defined From€Profiling of 2€Independent Cohorts (2018) (0)
- P748Cardiac biomarkers and clinical scores for risk stratification in patients with severe symptomatic aortic stenosis undergoing TAVI. Which ranks first now (2017) (0)
- Decoy for Prevention of Early Atherosclerosis in Coronary Bypass Vein Grafts: A Volumetric IVUS Subanalysis From a Prospective Randomized Double Blind Clinical Trial (2016) (0)
- Abstract 13839: Systemic Inflammatory Response Syndrome Predicts Increased Mortality in Patients After Transcatheter Aortic Valve Implantation (2011) (0)
- Coronary interventions in the elderly--the German ALKK Study Group experience. (2001) (0)
- Abstract 3251: Long-Term Outcomes Following Treatment of In-Stent Restenosis with Drug-Eluting Stents: Insights from the TAXUS Meta-Analysis (2006) (0)
- A novel approach to aortocoronary saphenous venous graft percutaneous treatment (2011) (0)
- Impact of Transradial Versus Transfemoral Artery Approach for Pre-Procedural Coronary Angiography on Outcomes in Patients Undergoing Subsequent TAVR (2022) (0)
- Percutaneous therapy for aortic valve disease (2010) (0)
- Initial experiences with paclitaxel-eluting stents for treatment of de novo as well as in-stent restenotic lesions: TAXUS I and TAXUS III (2005) (0)
- [30-day mortality after heart surgery: a pilot project of the Working Party of Directors of Hospital Cardiology Departments]. (2008) (0)
- Retrograde endovascular aortic valve replacement: Initial experiences with the CoreValve® prosthesis (2006) (0)
- [Determination of the examination planes in two-dimensional sector echocardiography (author's transl)]. (1979) (0)
- Percutaneous Mitral Annuloplasty for Treatment of Functional Mitral Regurgitation (2009) (0)
- Abstract 13258: 3d Speckle Tracking Analysis of Left Ventricular Function after Transcatheter Aortic Valve Implantation (2012) (0)
- Consideration of the feasibility of transcatheter aortic valve implantation using cardiac computed tomography – Case report of a patient with severe aortic stenosis and undiagnosed coronary anomaly (2010) (0)
- ong-Term Impact of Routinely Detected arly and Late Incomplete Stent Apposition (0)
- [Cardiac effects of isoproterenol in the complex echocardiographic evaluation (author's transl)]. (1980) (0)
- P6345Systemic inflammatory response syndrome following TAVI: what role do next generation transcatheter heart valves (THVs) play? (2017) (0)
- [Comparison between i.a. DSA and cineangiography for evaluating the coronary arteries and the left ventricle]. (1986) (0)
- The renal resistance index for the non-invasive assessment of paravalvular aortic regurgitation after transcatheter aortic valve implantation (2013) (0)
- VESSEL RESPONSE TO THE NOVEL POLYMER-FREE BIOFREEDOM STENT VERSUS CONVENTIONAL DURABLE POLYMER COATING STENT: SHORT- AND MID-TERM INTRAVASCULAR ULTRASOUND RESULTS FROM THE BIOFREEDOM FIRST-IN-MAN TRIAL (2011) (0)
- TCT-872 Results of transfemoral TAVI in Partner-like Patients – A comparison with Real-World Patients (2012) (0)
- [Coronary spasms in selective coronary angiography]. (1979) (0)
- Advancing the Delivery System Across the Aorta and Valve (CoreValve) (2009) (0)
- P749Peri-procedural myocardial injury depends on transcatheter heart valve type but does not predict mortality in patients after tavi (2017) (0)
- TCT-692 The effect of balloon predilatation in TAVI on long-term mortality (2015) (0)
- [Motion analysis of the left ventricle by two dimensional sector echokardiography (author's transl)]. (1978) (0)
- TCT-730 Long-term performance of a transfemorally implantable nonmetallic, retrievable and repositionable aortic valve in patients with severe aortic stenosis- 5 Year Follow-Up of the 22 F-Direct Flow Medical Valve (2014) (0)
- TCT-772 The Effect of Appropriate Implant Position for the Evolut R Self-Expanding Transcatheter Aortic Valve: Analysis from the FORWARD Study (2017) (0)
- Abstract 12656: The Impact of Periprosthetic Aortic Regurgitation on Outcome in Patients After Transcatheter Aortic Valve Implantation (2011) (0)
- [Malignant fibrous mesothelioma of the pericardium]. (1981) (0)
- INCIDENCE, PREDICTORS AND IMPACT OF MAJOR BLEEDING IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (0)
- 2 Glomerular hyperfiltration in essential hypertension: correlation with hypertensive heart disease (1988) (0)
- Nine-month results of the TROPICAL study: a multicenter nonrandomized study of the Cypher((TM)) sirolimus-eluting stent in the treatment of patients with an instent restenotic native coronary artery lesion (2004) (0)
- Saphenous vein grafts and arterial conduits (2007) (0)
- Predictive value of the Fibrosis-4 index in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (2022) (0)
- PRELIMINARY ANGIOGRAPHIC RESULTS OF THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS FOR THE TREATMENT OF CORONARY ARTERY LESIONS - FOUR-MONTH ANGIOGRAPHIC FOLLOW-UP OF THE PROSPECTIVE, RANDOMIZED, MULTICENTER BIOFREEDOM TRIAL (2010) (0)
- [Computer-cardio-tomography in idiopathic hypertrophic subvalvular aortic stenosis--a new contribution to non-invasive diagnosis (author's transl)]. (1979) (0)
- [Heart involvement in progressive systemic sclerosis (generalized scleroderma)]. (1984) (0)
- Influence of calcium on neointimal growth following drug-eluting and bare metal stents implantation: A 3-D intravascular ultrasound substudy of the SCORE trial (2003) (0)
- [Embolism prevention during interventional treatment of aortocoronary bypass stenoses]. (2001) (0)
- CRT-707 The Impact of Acute and Chronic Troponin Elevation After Transcatheter Aortic Valve Implantation (2014) (0)
- P6403Impact of hemodynamic support on outcome in patients undergoing high-risk percutaneous coronary intervention (2018) (0)
- TCT-674 Implication of peri-procedural biomarker elevation after stent implantation: analysis from the pooled XIENCE V trials (2012) (0)
- Drug-Eluting Stents Current clinical experience and future directions (0)
- New journal for the interventional cardiology community (2009) (0)
- [Comparative postoperative studies following implantation of synthetic and xenograft prosthesis in the mitral position. An echocardiographic study]. (1977) (0)
- Abstract 2774: Six-Month IVUS Analysis of Long Coronary Artery Lesions Treated with Biolimus-A9 Eluting XTENT interdigitating stent with bioabsorbable polymer: Results of the CUSTOM II Trial (2007) (0)
- Directional atherectomy for treatment of stent restenosis — feasibility and histopathological findings in 28 patients (1998) (0)
- TCT-594 Five year and Final Report of BioFreedom First-In-Man, a Randomized Trial comparing Polymer-Free BioFreedom™ stents with Durable Polymer Taxus Liberté™ Stents (2014) (0)
- [The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome]. (1983) (0)
- DEGREE AND DISTRIBUTION OF AORTIC ANNULUS CALCIFICATION AS A PREDICTIVE FACTOR FOR PACEMAKER IMPLANTATION AFTER COREVALVE TAVI. A CT DRIVEN, PROSPECTIVE, SINGLE-CENTER STUDY (2010) (0)
- Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation (2020) (0)
- Microstent to GFX: Experience in 2,325 Patients (1998) (0)
- [Echocardiographic contrast studies for the delineation of the heart cavities using peripheral venous sodium chloride injections. A contribution to shunt diagnosis]. (1977) (0)
- ECG in Atrial and Ventricular Arrhythmias Abstract 1741 : Predicting Coronary Stenosis by Computer-Enhanced , Resting Electrocardiogram : Effect of Gender , Age , and Revascularization on Sensitivity and Specificity (2007) (0)
- TCT-771 30-Day Outcomes in Patients with a Society of Thoracic Surgeons Predicted Risk of Mortality <3% from the Evolut R FORWARD Study (2017) (0)
- Abstract 13910: The Impact of Peripheral Arterial Disease on Early Outcome After Transcatheter Aortic Valve Implantation. Results From the German TAVI Registry. (2011) (0)
- 2648 – EFFECT OF INTRAVENOUS QUINIDINE ON LEFT VENTRICULAR PERFORMANCE (1978) (0)
- NONPOLYMER-BASED BIOLIMUS-ELUTING STENT ACCELERATES OVERALL NEOINTIMAL COVERAGE: SHORT- AND MID-TERM INTRAVASCULAR ULTRASOUND RESULTS FROM STEALTH AND BIOFREEDOM TRIALS (2011) (0)
- [Quantitative regional functional analysis of the left ventricle using ECG-directed cardiac computerized tomography]. (1987) (0)
- Catch me, if you can! (2012) (0)
- Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment Interventional Cardiology (2007) (0)
- High‐Frequency Mechanical Revascularization (2013) (0)
- 2293 – EVALUATION OF ECHOCARDIOGRAPHIC PARAMETERS IN CORRELATION TO PLASMA LEVELS OF PROPRANOLOL (1978) (0)
- Why we should never return to bare metal stents? (2008) (0)
- Is the Quantification of Mitral Stenosis and Aortic Stenosis by Transesophageal Echocardiography Feasible (1989) (0)
- Paclitaxel-eluting coronary stent implantation in calcified coronary lesions (2006) (0)
- Percutaneous aortic valve implantation – an experience with the LotusTM repositionable device (2015) (0)
- [Surgical or interventional aortic valve repair? Pro interventional repair]. (2008) (0)
- Percutaneous Implantation of Aortic Valvular Prosthesis (Self‐Expanded Prosthesis) (2009) (0)
- VERY LONG-TERM SERIAL INTRAVASCULAR ULTRASOUND EVALUATION OF BIOLIMUSA9-ELUTING STENT WITH BIODEGRADABLE POLYMER (2011) (0)
- Tacrolimus eluting stents (2005) (0)
- [Paroxysmal tachycardic atrial fibrillation: termination by surgically induced A-V block (author's transl)]. (1975) (0)
- MANAGEMENT OF PARAVALVULAR AORTIC REGURGITATION AFTER TAVR: PROSPECTIVE EVALUATION OF THE AORTIC REGURGITATION INDEX (2013) (0)
- [Intermittent intra-aortic counterpulsation as therapy in threatening and manifest heart failure]. (1976) (0)
- CRT-200.54 Evaluation of 2-year Clinical Outcomes From Post-market Trials With Everolimus-eluting Cobalt Chromium Stents in Diabetics (2016) (0)
- Abstract 4498: Role of Self-Expanding Drug-Eluting Axxess Stent in Bifurcation Lesions: Intravascular Ultrasound Findings of AXXESS, AXXENT and DIVERGE Trials (2008) (0)
- IMPACT OF CHRONIC KIDNEY DISEASE ON OUTCOMES IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (0)
- ACUTE AND MID-TERM RESULTS FROM A FIM/APPROVAL TRIAL OF A 2ND GENERATION TRANSFEMORAL AORTIC BIOPROSTHESIS FOR THE TREATMENT OF PATIENTS WITH SEVERE AORTIC STENOSIS (2014) (0)
- [2-dimensional sector echocardiography]. (1979) (0)
- Predilation in Transcatheter Aortic Valve Implantation (2019) (0)
- An update on the current state of the CoreValve device (2008) (0)
- Symptom Control and Psychosocial Rehabilitation of Chronic Pacemaker Patients with Different Pacing Modes (1983) (0)
- TCT-813 Long-term performance of a transfemorally implantable nonmetallic, retrievable and repositionable aortic valve in patients with severe aortic stenosis 4 Year Follow-Up of the 22 F-Direct Flow Medical Valve (2012) (0)
- Emerging Technologies: Stents (2008) (0)
- Abstract 13245: Three-Dimensional Imaging of Aortic Valve Geometry Prior to Tavi Procedures: Comparison Between 3d-Transesophageal Echocardiography and Contrast Enhanced Computed Tomography (2012) (0)
- IS THERE A DIFFERENCE IN VASCULAR RESPONSE BETWEEN BIODEGRADABLE POLYMER-BASED VERSUS NONPOLYMER-BASED BIOLIMUS-ELUTING STENT? SHORT-TERM INTRAVASCULAR ULTRASOUND RESULTS FROM STEALTH AND BIOFREEDOM TRIAL (2010) (0)
- [Indoramin in severe cardiac insufficiency. Acute hemodynamic effectiveness]. (2008) (0)
- S44-1 PERCUTANEOUS AORTIC VALVE DEPLOYMENT (2007) (0)
- TCT-763 A Risk Prediction Algorithm for 1-Year Mortality after Transcatheter Aortic Valve Implantation (2013) (0)
- P6034Prognostic value of logistic EuroSCORE and STS-PROM in a recent patient cohort undergoing TAVI with next generation transcatheter heart valves (2018) (0)
- Abstract 1976: Angiographic versus Intravascular Ultrasound Parameters of Drug-Eluting Stent Efficacy: A Meta-Analysis from TAXUS IV, V and VI (2006) (0)
- Abstract 3791: Experience with 21 French Percutaneous CoreValve Aortic Valve Replacement in Patients Unsuitable for Surgical Aortic Valve Replacement (2006) (0)
- Automatic and Interactive Image Processing of 2-D Echocardiogramms for Analysis of Left Ventricular Function (1982) (0)
- Percutaneous theapy for aortic valve disease (2010) (0)
- Abstract 3389: Percutaneous Aortic Valve Replacement with a self expandable bioprosthesis: Early and Intermediate Echocardiographic Follow-up (2007) (0)
- COMPUTERIZED RESTING ECG ANALYSIS FOR THE DETECTION OF CORONARY ARTERY STENOSIS AFTER CORONARY REVASCULARIZATION IN COMPARISON WITH ANGIOGRAPHIC FINDINGS (2007) (0)
- EFFECT OF BIVALIRUDIN VERSUS HEPARIN IN A CONTEMPORARY TAVR POPULATION OF WOMEN: RESULTS FROM THE BRAVO 3 RANDOMIZED TRIAL (2016) (0)
- Impact of Pulmonary Hypertension on Outcome after Transcatheter Aortic Valve Implantation (2012) (0)
- Unbreak My Heart (Valve) (2017) (0)
- Combined percutaneous treatment of structural and congenital heart defects: more than just a feasible procedure in the catheterization laboratory (2015) (0)
- State-of-the-art TAVI - how much minimalism is enough? (2019) (0)
- Intraoperative Gene Therapy of Coronary Artery Bypass Vein Grafts with E2F-Decoy: A Volumetric IVUS Subanalysis from PREVENT II Study (2003) (0)
- [Significance of propranolol action on the AH-time for the diagnosis of normal and aberrant atrial-His correlations]. (1977) (0)
- P3417Reclassification into moderate aortic valve stenosis after hybrid continuity equation by combination of CT and echocardiography and its clinical impact (2018) (0)
- 1101-44 Effect of everolimus-eluting stents in preventing neointimal hyperplasia: An intravascular ultrasound analysis from the FUTURE II trial (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Eberhardt Grube?
Eberhardt Grube is affiliated with the following schools: